Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Early Detection of Side Effects in Metastatic Melanoma Patients Using Zirconium (89Zr) Crefmirlimab Berdoxam Imaging

    Recruiting

    2 1 1
    Investigated Diseases:
    Germany
  • Study on Reducing Bleomycin Dose in Electrochemotherapy for Patients with Skin Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Long-Term Safety Study of MB-CART19.1, MB-CART20.1, and Zamtocabtagene Autoleucel for Patients with Advanced Melanoma or B-Cell Malignancies

    Recruiting

    1 1 1
    Germany
  • Study on the Effectiveness and Safety of Lifileucel and Pembrolizumab for Patients with Untreated, Unresectable, or Metastatic Melanoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Czechia Finland France Germany Greece +6
  • Study on Tranexamic Acid to Reduce Early Relapse in Melanoma Patients Undergoing Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Study of Pembrolizumab for Children with Advanced Melanoma or PD-L1 Positive Solid Tumors and Lymphoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy The Netherlands Portugal Sweden
  • Study to Compare Fianlimab and Cemiplimab Combination with Pembrolizumab in Patients with High-Risk Melanoma After Surgery

    Recruiting

    3 1 1 1
    Belgium Czechia France Germany Greece Ireland +4
  • Study of 89Zirconium-labeled ipilimumab distribution in patients with metastatic melanoma receiving ipilimumab/nivolumab combination therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland Norway Sweden
  • DB-1311 in Combination with BNT327 or DB-1305 for Patients with Advanced or Metastatic Solid Tumors

    Not yet recruiting

    2 1 1
    France Germany Italy Poland Spain